Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

A Systematic Review on Curcumin and Anti-Plasmodium berghei Effects

Author(s): Pegah Shakib, Hamed Kalani, Jeffery Ho, Mehrdad Dolatshah, Sana Amiri and Kourosh Cheraghipour*

Volume 19, Issue 3, 2022

Published on: 11 April, 2022

Article ID: e150322202249 Pages: 6

DOI: 10.2174/1570163819666220315140736

Price: $65

conference banner
Abstract

Background: Turmeric (Curcuma longa L.) is a popular spice containing curcumin that is responsible for its therapeutic effects. Curcumin with anti-inflammatory, antioxidant, anti-cancer, and antimicrobial activities has led to a lot of research focusing on it over the years. This systematic review aimed to evaluate research on the anti-Plasmodium berghei activity of curcumin and its derivatives.

Methods: Our study was performed according to PRISMA guidelines and was recorded in the database of a systematic review and preclinical meta-analysis of CAMARADESNC3Rs (SyRF). The search was performed in five databases, namely Scopus, PubMed, Web of Science, EMBASE, and Google Scholar, from 2010 to 2020. The following keywords were searched: “Plasmodium berghei”, “Medicinal Plants”, “Curcumin”, “Concentration”, Animals kind”, “Treatment Durations”, “Routes of Administration” and “in vivo”.

Results: Of the 3,500 papers initially obtained, 14 articles were reliable and were thus scrutinized. Animal models were included in all studies. The most commonly used animal strain was Albino (43%), followed by C57BL/6 (22%). The other studies used various murine strains, including BALB/c (14%) and ICR (7%). Two (14%) studies did not mention the strain of animal model used. Curcumin alone or in combination with other compounds depending on the dose used, route of administration, and animal model showed a moderate to strong anti-Plasmodium berghei effect.

Conclusion: According to the studies, curcumin has anti-malarial effects on Plasmodium berghei, and, however, its effect on human Plasmodium is unclear. Due to the side effects and drug resistance of current drugs in the treatment of human malaria, the use of new compounds with few or no side effects, such as curcumin, is recommended as an alternative or complementary treatment.

Keywords: Plasmodium berghei, Curcumin longa, parasitic activity, anti-infective agent, in vivo, zingiberaceae family.

Graphical Abstract

[1]
Oyelade J, Isewon I, Uwoghiren E, Aromolaran O, Oladipupo O. In silico knockout screening of Plasmodium falciparum reactions and prediction of novel essential reactions by analysing the metabolic network. BioMed Res Inter 2018; 2018, 89857180.
[http://dx.doi.org/10.1155/2018/8985718]
[2]
Nateghpour M, Edrissian G, Torabi A, et al. Monitoring of Plasmodium vivax and Plasmodium falciparum response to chloroquine in Bandar-Abbas district, Hormozgan province, Iran. Tehran Univ Med J 2009; 67(3): 31-8.
[3]
Flegg JA, Guérin PJ, Nosten F, et al. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Malar J 2013; 12(1): 411.
[http://dx.doi.org/10.1186/1475-2875-12-411] [PMID: 24225303]
[4]
Garedaghi Y, Khaki A. Evaluation of the effectiveness of ethanolic extract of solanum surattense against plasmodium berghei in comparison with chloroquine in sourian mice using in vivo tests. Crescent J Med Biol Sci 2014; 1(3): 76-9.
[5]
Elmi T, Gholami S, Azadbakht M, Ziaei H. Effect of chloroformic extract of tanacetum parthenium in the treatment of Giardia lamblia infection in Balb/c Mice. J Mazandaran Univ Med Sci 2014; 23(1): 157-65.
[6]
Bhattacharjee D, Shivaprakash G. Drug resistance in malaria-in a nutshell. J Appl Pharm Sci 2016; 6(3): 137-43.
[http://dx.doi.org/10.7324/JAPS.2016.60324]
[7]
Karimi S, Tahghighi A. A review to theimportance of quinolone ring in achieving new anti-malarial drugs. Majallah-i Ulum-i Pizishki-i Razi 2016; 23(142): 11-9.
[8]
Elmi T, Gholami S, Azadbakht M, Rahimi-Osboei B, Garayli Z. The effects of hydroalcoholic extract of leaves and onion of Allium paradoxum on Giardia lamblia in mice. Shahrekord Univ Med Sci J 2014; 16(5): 13-22.
[9]
Aggarwal BB, Surh Y-J, Shishodia S. The molecular targets and therapeutic uses of curcumin in health and disease. Springer Science & Business Media 2007.
[http://dx.doi.org/10.1007/978-0-387-46401-5]
[10]
Agarwal A, Saxena PN. Curcumin, a polyphenol from the Curcuma longa, prevents mercuric chloride-induced liver damage through reversal of oxidative stress and biochemical changes. In: Proceedings: AACR Annual Meeting 2018. April 14-18, 2018; Chicago, IL:.
[11]
Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23(1A): 363-98.
[PMID: 12680238]
[12]
Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009; 30(2): 85-94.
[http://dx.doi.org/10.1016/j.tips.2008.11.002] [PMID: 19110321]
[13]
Cheraghipour K, Marzban A, Ezatpour B, Khanizadeh S, Koshki J. Antiparasitic properties of curcumin: A review. AIMS Agric Food 2018; 4: 561.
[14]
Cheraghipour K, Ezatpour B, Masoori L, et al. Anti-candida activity of Curcumin: a review. Curr Drug Discovery Technol 2021; 18(3): 379-90.
[http://dx.doi.org/10.2174/1570163817666200518074629]
[15]
Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z. Antiviral potentials of medicinal plants. Virus Res 2008; 131(2): 111-20.
[http://dx.doi.org/10.1016/j.virusres.2007.09.008] [PMID: 17981353]
[16]
Busari ZA, Dauda KA, Morenikeji OA, et al. Antiplasmodial activity and toxicological assessment of curcumin PLGA-encapsulated nanoparticles. Front Pharmacol 2017; 8: 622.
[http://dx.doi.org/10.3389/fphar.2017.00622] [PMID: 28932197]
[17]
Dende C, Meena J, Nagarajan P, Panda AK, Rangarajan PN, Padmanaban G. Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria. Sci Rep 2015; 5: 12671.
[http://dx.doi.org/10.1038/srep12671] [PMID: 26227888]
[18]
Ghosh A, Banerjee T, Bhandary S, Surolia A. Formulation of nanotized curcumin and demonstration of its antimalarial efficacy. Int J Nanomedicine 2014; 9: 5373-87.
[http://dx.doi.org/10.2147/IJN.S62756] [PMID: 25484584]
[19]
Mishra K, Dash AP, Dey N. Andrographolide: a novel antimalarial diterpene lactone compound from Andrographis paniculata and its interaction with curcumin and artesunate. J Trop Med 2011; 2011Article ID 579518
[http://dx.doi.org/10.1155/2011/579518]
[20]
Vathsala PG, Dende C, Nagaraj VA, et al. Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation. PLoS One 2012; 7(1), e29442.
[http://dx.doi.org/10.1371/journal.pone.0029442] [PMID: 22276114]
[21]
Isacchi B, Bergonzi MC, Grazioso M, et al. Artemisinin and artemisinin plus curcumin liposomal formulations: Enhanced antimalarial efficacy against Plasmodium berghei-infected mice. Eur J Pharm Biopharm 2012; 80(3): 528-34.
[http://dx.doi.org/10.1016/j.ejpb.2011.11.015] [PMID: 22142592]
[22]
Aditya NP, Chimote G, Gunalan K, Banerjee R, Patankar S, Madhusudhan B. Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice. Exp Parasitol 2012; 131(3): 292-9.
[http://dx.doi.org/10.1016/j.exppara.2012.04.010] [PMID: 22561991]
[23]
Memvanga PB, Coco R, Préat V. An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether. J Control Release 2013; 172(3): 904-13.
[http://dx.doi.org/10.1016/j.jconrel.2013.09.001] [PMID: 24021359]
[24]
Laware Rb, Kuchekar Bs. Curcumin-Zn-artemether combination therapy for plasmodium berghei infected mice. Int J Pharm Pharm Sci 2015; 7(9): 41-5.
[25]
Ali AH, Sudi S, Basir R, Embi N, Sidek HM. The antimalarial effect of curcumin is mediated by the inhibition of glycogen synthase kinase-3β. J Med Food 2017; 20(2): 152-61.
[http://dx.doi.org/10.1089/jmf.2016.3813] [PMID: 28146408]
[26]
Dende C, Meena J, Nagarajan P, Nagaraj VA, Panda AK, Padmanaban G. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria. Sci Rep 2017; 7(1): 10062.
[http://dx.doi.org/10.1038/s41598-017-10672-9] [PMID: 28855623]
[27]
Oyeyemi O, Morenkeji O, Afolayan F, et al. Curcumin-artesunate based polymeric nanoparticle; antiplasmodial and toxicological evaluation in murine model. Front Pharmacol 2018; 9: 562.
[http://dx.doi.org/10.3389/fphar.2018.00562] [PMID: 29899700]
[28]
Thakkar M, Brijesh S. Physicochemical investigation and in vivo activity of anti-malarial drugs co-loaded in Tween 80 niosomes. J Liposome Res 2018; 28(4): 315-21.
[http://dx.doi.org/10.1080/08982104.2017.1376684] [PMID: 28874081]
[29]
Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A. In vivo antiplasmodial activity of curcumin-loaded nanostructured lipid carriers. Curr Drug Deliv 2019; 16(10): 923-30.
[http://dx.doi.org/10.2174/1567201816666191029121036] [PMID: 31663477]

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy